Clinical trial
A Phase II, Open-Label Study To Assess The Efficacy and Tolerability of ZD6474 (ZACTIMA� ) 100 mg Monotherapy In Subjects with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
To determine the objective response rate in subjects treated with ZD6474 (ZACTIMA� ) 100 mg monotherapy
| Category | Value |
|---|---|
| Study start date | 2006-04-20 |